PlaCor came to Wi through one of our hardware partners looking to implement a technology capable of detecting activation of platelets. The market was in need of a device that could determine the efficacy of statin drugs and low dose aspirin regiments. PlaCor needed a cartridge incorporating their technology and a hardware receiver mechanism to interface with the consumable. The entire program was executed within 4 months.